Osteoporosis References |
|
Alfven T, Elinder CG, Carlsson MD, et al. Low-level cadmium exposure and osteoporosis. J Bone Miner Res. Aug 2000;15(8):1579-1586. Barzel US, Massey LK. Excess dietary protein can adversely affect bone. J Nutr. Jun 1998;128(6):1051-1053. Braam LA, Knapen MH, Geusens P, et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int. Jul 2003;73(1):21-26. Bonaiuti D, Shea B, Iovine R, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. 2002(3):CD000333. Cashman KD. Calcium intake, calcium bioavailability and bone health. Br J Nutr. May 2002;87 Suppl 2:S169-177. Cefalu CA. Is bone mineral density predictive of fracture risk reduction? Curr Med Res Opin. Mar 2004;20(3):341-349. Conly J, Stein K. Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials. Clin Invest Med. Dec 1994;17(6):531-539. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ, 3rd. Population-based study of survival after osteoporotic fractures. Am J Epidemiol. May 1 1993;137(9):1001-1005. Dennison E, Hindmarsh P, Fall C, et al. Profiles of Endogenous Circulating Cortisol and Bone Mineral Density in Healthy Elderly Men. J Clin Endocrinol Metab. September 1, 1999;84(9):3058-3063.
Ferland G, Sadowski JA,
O'Brien ME. Dietary induced subclinical vitamin K deficiency in normal human
subjects. J Clin Invest. Apr 1993;91(4):1761-1768. Gaby A. Preventing and reversing osteoporosis and arthritis. Rocklin, CA: Prima Publishing; 1994. Gaby AR. Diagnostic tests for osteoporosis. Townsend Letters for Doctors and Patients. October 31 1998. Gregg EW, Cauley JA, Seeley DG, Ensrud KE, Bauer DC. Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med. Jul 15 1998;129(2):81-88. Hall SL, Greendale GA. The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study. Calcif Tissue Int. Oct 1998;63(3):183-189. Hampton T. Experts urge early investment in bone health. Jama. Feb 18 2004;291(7):811-812. Hara K, Kobayashi M, Akiyama Y. Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone. Nov 2002;31(5):575-581. Hara K, Kobayashi M, Akiyama Y. Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone. Nov 2002;31(5):575-581. Harris SS, Dawson-Hughes B. Caffeine and bone loss in healthy postmenopausal women. Am J Clin Nutr. Oct 1994;60(4):573-578. Heaney RP. Effects of caffeine on bone and the calcium economy. Food Chem Toxicol. Sep 2002;40(9):1263-1270. Heaney RP. Long-latency deficiency disease: insights from calcium and vitamin D. Am J Clin Nutr. November 1, 2003 2003;78(5):912-919. Hodges SJ, Pilkington MJ, Shearer MJ, Bitensky L, Chayen J. Age-related changes in the circulating levels of congeners of vitamin K2, menaquinone-7 and menaquinone-8. Clin Sci (Lond). Jan 1990;78(1):63-66. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004;79(3):362-371. Hyun TH, Barrett-Connor E, Milne DB. Zinc intakes and plasma concentrations in men with osteoporosis: the Rancho Bernardo Study. Am J Clin Nutr. September 1, 2004;80(3):715-721. Iketani T, Kiriike N, B. Stein M, et al. Effect of menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia nervosa. Psychiatry Research. 2003;117(3):259-269. Iwamoto J, Takeda T, Ichimura S. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis. J Orthop Sci. 2000;5(6):546-551. Iwamoto J, Takeda T, Sato Y, Yeh JK. Effect of vitamin K2 and growth hormone on the long bones in hypophysectomized young rats: a bone histomorphometry study. J Bone Miner Metab. 2007;25(1):46-53. Knapen MH, Schurgers LJ, Vermeer C. Vitamin K(2) supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int. Feb 8 2007. Knutson D, Greenberg G, Cronau H. Management of crohn's disease--a practical approach. Am Fam Physician. 2003;68:707-714. Krane S, Holick M. Metabolic Bone Disease: Osteoporosis. In: Isselbacher K, Brunwald E, Wilson J, eds. Harrison's Textbook of Internal Medicine. New York: McGraw Hill, Inc.; 1994:2172-2176. Lean JM, Davies JT, Fuller K, et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest. Sep 2003;112(6):915-923. Lydeking-Olsen E, Beck-Jensen JE, Setchell KD, Holm-Jensen T. Soymilk or progesterone for prevention of bone loss: a 2 year randomized, placebo-controlled trial. Eur J Nutr. Aug 2004;43(4):246-257. Macera CA. Exercise and risk of hip fracture in postmenopausal women. Clin J Sport Med. Mar 2004;14(2):103-104. Maggio D, Barabani M, Pierandrei M, et al. Marked Decrease in Plasma Antioxidants in Aged Osteoporotic Women: Results of a Cross-Sectional Study. J Clin Endocrinol Metab. April 1, 2003;88(4):1523-1527. Mannius S, Mellstrom D, Lindstedt G, Rundgren, Zetterberg C. Health status and risk for hip fracture: a case control study of 70-75-year-olds. Arch Gerontol Geriatr. Sep-Oct 1992;15(2):151-162. Maurer M, Riesen W, Muser J, Hulter HN, Krapf R. Neutralization of Western diet inhibits bone resorption independently of K intake and reduces cortisol secretion in humans. Am J Physiol Renal Physiol. January 1, 2003 2003;284(1):F32-40. McGarry KA, Kiel DP. Postmenopausal osteoporosis. Strategies for preventing bone loss, avoiding fracture. Postgrad Med. Sep 1 2000;108(3):79-82, 85-78, 91. McLean RR, Jacques PF, Selhub J, et al. Homocysteine as a Predictive Factor for Hip Fracture in Older Persons. N Engl J Med. May 13, 2004;350(20):2042-2049. Melhus H, Michaelsson K, Holmberg L, Wolk A, Ljunghall S. Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res. Feb 1999;14(1):129-135. Meyer HE, Pedersen JI, Loken EB, Tverdal A. Dietary factors and the incidence of hip fracture in middle-aged Norwegians. A prospective study. Am J Epidemiol. Jan 15 1997;145(2):117-123. Miller AL. Cardiovascular Disease--Toward a Unified Approach. Alt Med Rev. 1996;1(3):132-147. Murray MT, Pizzorno JE. Osteoporosis. Textbook of Natural Medicine. 2nd ed: Churchill Livingstone; 1999. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease. N Engl J Med. July 24, 1997;337(4):230-237. Okada Y, Tanaka Y. Immune signals in the context of secondary osteoporosis. Histol Histopathol. Jul 2004;19(3):863-866. Old JL, Calvert M. Vertebral compression fractures in the elderly. Am Fam Physician. Jan 1 2004;69(1):111-116. Pelton R, LaValle J, Hawkins E, Krinsky D. Drug-Induced Nutrient Depletion Handbook. 2d ed. Hudson, OH: Lexi-Comp; 2001. Plaza SM, Lamson DW. Vitamin K2 in bone metabolism and osteoporosis. Altern Med Rev. Mar 2005;10(1):24-35. Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl J Med. Oct 24 1991;325(17):1189-1195. Thomas TN. Lifestyle risk factors for osteoporosis. Medsurg Nurs. Oct 1997;6(5):275-277, 287. Purwosunu Y, Rachman IA, Reksoprodjo S, Sekizawa A. Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia. Journal of Obstetrics and Gynaecology Research. 2006;32(2):230-234. Remer T, Manz F. Estimation of the renal net acid excretion by adults consuming diets containing variable amounts of protein. Am J Clin Nutr. Jun 1994;59(6):1356-1361. Roggia C, Gao Y, Cenci S, et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A. Nov 20 2001;98(24):13960-13965. Roggia C, Tamone C, Cenci S, Pacifici R, Isaia GC. Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency. Minerva Med. Apr 2004;95(2):125-132. Russell RM. Factors in Aging that Effect the Bioavailability of Nutrients. J. Nutr. April 1, 2001;131(4):1359S-1361. Sasaki N, Kusano E, Takahashi H, et al. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG). J Bone Miner Metab. 2005;23(1):41-47. Sato Y, Honda Y, Kuno H, Oizumi K. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone. Sep 1998;23(3):291-296. Sato Y, Kanoko T, Satoh K, Iwamoto J. Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease. Bone. 2005;36(1):61-68. Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2 (Menatetrenone) Effectively Prevents Fractures and Sustains Lumbar Bone Mineral Density in Osteoporosis. Journal of Bone and Mineral Research. 2000;15(3):515-522. Sontakke AN, Tare RS. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clinica Chimica Acta. 2002;318(1-2):145-148. Sunyer T, Lewis J, Collin-Osdoby P, Osdoby P. Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells. J. Clin. Invest. May 15, 1999 1999;103(10):1409-1418. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res. 1994;9:1591-1595. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr. April 1, 1999 1999;69(4):727-736. Upchurch GR, Jr., Welch GN, Fabian AJ, et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem. Jul 4 1997;272(27):17012-17017. Uriu K, Morimoto I, Kai K, et al. Uncoupling between bone formation and resorption in ovariectomized rats with chronic cadmium exposure. Toxicol Appl Pharmacol. May 1 2000;164(3):264-272. Ushiroyama T, Ikeda A, Ueki M. Effect of continuous combined therapy with vitamin K2 and vitamin D3 on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas. 2002;41(3):211-221. van Meurs JBJ, Dhonukshe-Rutten RAM, Pluijm SMF, et al. Homocysteine Levels and the Risk of Osteoporotic Fracture. N Engl J Med. May 13, 2004;350(20):2033-2041. Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum. Nov 2003;48(11):3224-3229. Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. June 2000;15(6):993-1000. Wang H, Zhu G, Shi Y, et al. Influence of environmental cadmium exposure on forearm bone density. J Bone Miner Res. Mar 2003;18(3):553-560. Wang MC, Luz Villa M, Marcus R, Kelsey JL. Associations of vitamin C, calcium and protein with bone mass in postmenopausal Mexican American women. Osteoporos Int. 1997;7(6):533-538. Wolff I, van Croonenborg JJ, Kemper HC, Kostense PJ, Twisk JW. The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int. 1999;9(1):1-12. Yun AJ, Lee PY. Maldaptation of the link between inflammation and bone turnover may be a key determinant of osteoporosis. Medical Hypotheses. 2004;63(3):532-537.
* * * We hope you found this message to be useful. However, if prefer not receive future enewsletters, please visit the opt-out link here: http://www.montanaim.com/remove.asp. If someone forwarded you this newsletter and you'd like to sign up to receive future ones, visit our sign up page here: http://www.montanaim.com/newsletter.asp.
Montana Integrative Medicine |
 |